These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2853743)

  • 21. Application of supercritical fluid chromatography to characterize a labile digitalis-like factor.
    Graves SW; Markides KE; Hollenberg NK
    Hypertension; 2000 Dec; 36(6):1059-64. PubMed ID: 11116125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography.
    De Angelis C; Riscazzi M; Salvini R; Piccoli A; Ferri C; Santucci A
    Clin Chem; 1997 Aug; 43(8 Pt 1):1416-20. PubMed ID: 9267322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Endogenous digitalis-like substance and Na-K-ATPase inhibitor in cardiovascular and renal disease].
    Okamoto S
    Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):39-50. PubMed ID: 2837414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium pump inhibition and regional expression of sodium pump alpha-isoforms in lens.
    Tao QF; Hollenberg NK; Graves SW
    Hypertension; 1999 Nov; 34(5):1168-74. PubMed ID: 10567200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of digitalislike factors from human plasma.
    Hamlyn JM; Schenden JA; Zyren J; Baczynskyj L
    Hypertension; 1987 Nov; 10(5 Pt 2):I71-7. PubMed ID: 2824370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation of a urinary digitalis-like factor indistinguishable from digoxin.
    Goto A; Ishiguro T; Yamada K; Ishii M; Yoshioka M; Eguchi C; Shimora M; Sugimoto T
    Biochem Biophys Res Commun; 1990 Dec; 173(3):1093-101. PubMed ID: 2176483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher plasma Na+,K+-ATPase inhibitory activity in essential hypertensive patients.
    Vasdev S; Fernandez PG; Longerich L; Gault H
    Can J Cardiol; 1989; 5(5):249-54. PubMed ID: 2547501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
    Kramer HJ; Baecker A; Weiler E; Liddiard C
    Klin Wochenschr; 1986 Aug; 64(16):760-6. PubMed ID: 3020314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma ouabain-like activity in essential hypertensive patients and in subjects with primary aldosteronism.
    Delva P; Degan M; Capra C; Fallo F; Mantero F; Menegazzi M; Lechi C; Steele A; Lechi A
    Miner Electrolyte Metab; 1989; 15(5):315-20. PubMed ID: 2554104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma digitalis-like activity and cytosolic Ca2+ in essential hypertension.
    Le Quan Sang KH; Pernollet MG; Meyer P; Devynck MA
    Am J Hypertens; 1990 Mar; 3(3):171-5. PubMed ID: 2157464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
    J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological activity of partially purified digitalis-like substance and Na-K-ATPase inhibitor in rats.
    Morise T; Okamoto S; Takasaki H; Ikeda M; Takeda R; Kiuti F; Tuda Y
    Jpn Circ J; 1988 Nov; 52(11):1309-16. PubMed ID: 2852264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous inhibitors of the Na+, K(+)-pump and platelet Ca2+ handling in hypertension.
    Devynck MA; David-Dufilho M; Astarie C; Mazeaud M; Pernollet MG; Le Quan Sang KH
    Physiol Bohemoslov; 1990; 39(1):71-8. PubMed ID: 2165268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A quantitative receptor assay for "digitalis-like" compounds in serum. Demonstration of raised concentrations in essential hypertension and correlation with arterial blood pressure.
    Moreth K; Renner D; Schoner W
    Klin Wochenschr; 1987 Feb; 65(4):179-84. PubMed ID: 3031360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Endogenous ouabain--key to the genesis of hypertension?].
    Blaustein MP; Hamlyn JM
    Dtsch Med Wochenschr; 1991 Nov; 116(44):1689-91. PubMed ID: 1657565
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of ouabain-like factors and Na-K-ATPase inhibitors in hypertension--some old and recent findings.
    Haddy FJ; Pamnani MB
    Clin Exp Hypertens; 1998; 20(5-6):499-508. PubMed ID: 9682906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous natriuretic and ouabain-like factors. Their roles in body fluid volume and blood pressure regulation.
    Kramer HJ; Meyer-Lehnert H; Michel H; Predel HG
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):81-9. PubMed ID: 1848764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent progress on an endogenous digitalislike factor in hypertension.
    Cloix JF; Crabos M; Meyer P
    J Clin Hypertens; 1986 Jun; 2(2):93-100. PubMed ID: 3020179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
    Boschi S; Borghi C; Munarini A; Costa FV; Lu ZR; deVries D; Ambrosioni E
    Biochem Biophys Res Commun; 1990 Jun; 169(2):360-8. PubMed ID: 2162662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.